European shares fell on Friday
European shares fell on Friday after a rally in the previous session on a sharp interest rate cut by the US Federal Reserve, while shares of drugmaker Novo Nordisk fell on disappointing data on an anti-obesity drug.
The European Stoxx 600 index closed up 1.4%, while it fell 0.33% during the week.
All major European stock markets posted heavy losses, with the exception of the Spanish stock market, whose main index lost only 0.2%, according to Reuters.
Shares in Novo Nordisk fell 5.4% after the results of the first phase 2 trial of the Danish manufacturer's experimental obesity drug monlunabant failed to meet market expectations .
The health sector index fell by 1.9%. The auto index led the decline among the main European index sectors, down 3.6%, penalized by a 6.8% drop in Mercedes-Benz, which cut its target of the profit margin for the second time in less than two months.
The shares of other competitors in the sector fell, such as Volkswagen, whose shares fell by 3.4%, and Forvia of France, whose shares lost 8%.
Technology shares fell 2.7%, with Dutch chipmaker ASML losing 4.2% after Morgan Stanley downgraded the stock to underperform, predicting it would outperform the sector index.
Global stocks rose sharply on Thursday as the Federal Reserve kicked off its monetary easing cycle on Wednesday with a massive 50 basis point cut in interest rates.